What are the side effects of ELAHERE 5 mg/mL, solution à diluer pour perfusion?

This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems . For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme

Can ELAHERE 5 mg/mL, solution à diluer pour perfusion be used during pregnancy?

( AHT ) For the active ingredient mirvetuximab soravtansine You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Who manufactures ELAHERE 5 mg/mL, solution à diluer pour perfusion?

ABBVIE DEUTSCHLAND (ALLEMAGNE) (FR)

OTC

ELAHERE 5 mg/mL, solution à diluer pour perfusion

INN: MIRVÉTUXIMAB SORAVTANSINE

Data updated: 2026-04-11

Available in:

🇩🇪🇬🇧🇫🇷

Form

—

Dosage

—

Route

—

Storage

—

About This Product

Manufacturer

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.